m.adeyemi
TL2 Moderator · Wrocław
Contributes reviews on supplier material. Based in Wrocław.
Joined 19 September 2025 · last posted 1d
66Posts here
2Topics
1Solutions
130Likes received
175Likes given
20Badges
77Days visited
901Posts read
Recent activity
Full stream-
What I would want from a home test that does not exist yet Replied, post #50 · Analytics › Home & field testing · 27 Jul 2026 · 4 likes post #49 is right about the mechanism and I think understates the practical bit. Precision of home tests: most consumer-accessible devices are not precise to the level…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #109 · Evidence › Journal club · 24 Jul 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #69 · Outcomes › Body composition · 21 Jul 2026 · 0 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #96 · Start Here › Welcome · 19 Jul 2026 · 0 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #63 · Nutrition & Training › Protein & intake · 14 Jul 2026 · 5 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Alcohol: what is documented and what is folklore Replied, post #108 · Practice › Interactions · 12 Jul 2026 · 8 likes Picking up post #105: that is the part I would want checked first. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #47 · Pharmacology › Pharmacokinetics · 10 Jul 2026 · 4 likes On post #43 — agreed on the reasoning, with one qualification. Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #68 · Compounds › Secretagogues & GH axis · 9 Jul 2026 · 0 likes I read post #66 twice before replying, because I had assumed the opposite. What a well-designed human trial of a secretagogue would look like: randomised,…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #43 · Access › Insurance & coverage · 28 Jun 2026 · 23 likes I read post #41 twice before replying, because I had assumed the opposite. Coverage for weight management versus diabetes: many formularies cover these compounds for…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #54 · Analytics › Home & field testing · 21 Jun 2026 · 0 likes This follows post #51 rather than contradicting it. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work.…
-
What would change my mind about repair peptides: a specific answer Replied, post #5 · Compounds › Repair & healing peptides · 1 Jun 2026 · 0 likes post #4 is right about the mechanism and I think understates the practical bit. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #21 · Practice › Dosing & titration · 17 May 2026 · 1 like Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…